July 2022 Price Hikes Methodology and Data Set
Methodology and Dataset for July 2022 Price Hikes Report
The current drug pricing system isn’t working for patients like me.
My name is Emily. I’m a 26-year-old from Washington, D.C., and I live with psoriatic arthritis.
NEW REPORT: Big Pharma’s Lockstep Price Hikes On Widely Used Blood Thinners Exploit Patients And Taxpayers
A new report issued today documents how drug companies use their market and political power to avoid competition and raise prices in lockstep.
ELIQUIS AND XARELTO: LOCKSTEP PRICE HIKES AND PATENT GAMING EXPLOIT PATIENTS AND TAXPAYERS
This report examines the practices of BMS/Pfizer and Johnson & Johnson's lockstep price hikes and patent gaming on two blockbuster blood thinners and the implications for patients and taxpayers.
JANUARY PRICE HIKES 2.0: Big Pharma Pushes Blockbuster Prices To New Heights
Since P4AD’s initial report in mid-January, drug companies have increased the price of 188 more drugs, bringing the total to 742 hikes so far this year.
Round 2 Of January 2022 Hikes Pushes Blockbuster Prices To New Heights
Drug companies raised the prices of 742 drugs in January 2022
January Price Hikes 2.0 Methodology and Data Set
Methodology and Dataset for January Price Hikes 2.0 Report
JANUARY 2022 PRICE HIKES REPORT: A New Year Brings The Same Old Bad Behavior By Big Pharma
The report demonstrates why urgent congressional action is needed to address Big Pharma’s abusive pricing practices.
